Results 161 to 170 of about 7,297 (209)

The CD163 + tissue-infiltrating macrophages regulate ferroptosis in thyroid-associated ophthalmopathy orbital fibroblasts via the TGF-β/Smad2/3 signaling pathway. [PDF]

J Transl Med
Li X, Wang S, Cao H, Xu S, Xiong C, Yu J, Chen Y, Ren Z, Li M, Hu Y, Gan P, Xu Q, Wang Y, Liao H.   +13 more
europepmc   +1 more source

Progress in thyroid-associated ophthalmopathy.

Autoimmunity, 1997
J, Wall, J S, Kennerdell
openaire   +1 more source

Association between initial lipid and lipoprotein levels, oxidative stress indicators and clinical efficacy of intravenous methylprednisolone in moderate-to-severe thyroid-associated ophthalmopathy: protocol for a real-world prospective cohort study. [PDF]

BMJ Open
Liu S, Lu S, Xiong W, Zhang F.
europepmc   +1 more source

Diagnostic precision in thyroid-associated ophthalmopathy using multi-center radiomics with ^99mTc-DTPA SPECT/CT. [PDF]

Sci Rep
Liu Y, Li M, Chen H, Liu W, Hu M, Hu F, Ma L, Hu S, Zhao M, Cao W, Xia X.   +10 more
europepmc   +1 more source

Comparative effectiveness of various orbital decompression techniques in treating thyroid-associated ophthalmopathy: a systematic review and meta-analysis. [PDF]

BMC Ophthalmol
Guo W, Geng J, Li D.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Rituximab for thyroid-associated ophthalmopathy

Cochrane Database of Systematic Reviews, 2022
Thyroid-associated ophthalmopathy (TAO) is the most frequent extrathyroidal manifestation of Graves' disease, affecting up to 50% of patients. It has a great impact on quality of life. Rituximab (RTX) is a human/murine chimeric monoclonal antibody that targets the CD20 receptor on B-lymphocytes.
Swan, Kang, Shirin, Hamed Azzam, Neda, Minakaran, Daniel G, Ezra   +3 more
openaire   +4 more sources

Pathogenesis of thyroid-associated ophthalmopathy

Trends in Endocrinology & Metabolism, 1993
Thyroid-associated ophthalmopathy is a complex disease whose pathogenesis is thought to be autoimmune. Evidence has accumulated to implicate lymphocytes, antibodies, and cytokines targeting the orbital tissues whose structural and functional characteristics are unique.
P, Perros, P, Kendall-Taylor
openaire   +2 more sources

2021 update on thyroid-associated ophthalmopathy

Journal of Endocrinological Investigation, 2021
Our understanding of thyroid-associated ophthalmopathy (TAO, A.K.A Graves' orbitopathy, thyroid eye disease) has advanced substantially, since one of us (TJS) wrote the 2010 update on TAO, appearing in this journal.PubMed was searched for relevant articles.Recent insights have resulted from important studies conducted by many different laboratory ...
E. J. Neag, T. J. Smith
openaire   +2 more sources

The pathogenesis of thyroid-associated ophthalmopathy

Journal of Endocrinology, 1989
TAO is an autoimmune disease the pathogenesis of which is unclear. Autoimmunity against orbital antigens has been demonstrated, although the precise immunological mechanisms responsible are unidentified. Cytokines probably play an important mediating role.
P, Perros, P, Kendall-Taylor
openaire   +2 more sources

Thyroid-Associated Ophthalmopathy

2011
Eye symptoms are a common feature of Graves’ disease, where the symptoms have an underlying immunological cause. Several designations have been used: endocrine ophthalmopathy, dysthyroid orbitopathy, dysthyroid ophthalmopathy, orbitopathy, infiltrative ophthalmopathy and thyroid-associated ophthalmopathy (TAO).
Ernst Nyström, Gertrud E. B. Berg, Svante K. G. Jansson, Ove Tørring, Stig V. Valdemarsson   +4 more
openaire   +1 more source